Alaunos Therapeutics, Inc.
Pharmaceutical company · Fort Lauderdale, Florida, United States · Nasdaq: TCRT
Alaunos Therapeutics, Inc. is a pharmaceutical company headquartered in Fort Lauderdale, Florida, United States. Its shares trade on Nasdaq under the ticker TCRT. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2019.
Alaunos Therapeutics at a glance
What does Alaunos Therapeutics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $19.5 million sold (2019).
Frequently asked questions about Alaunos Therapeutics
Where is Alaunos Therapeutics headquartered?
Alaunos Therapeutics, Inc. is headquartered in Fort Lauderdale, Florida, United States.
What does Alaunos Therapeutics do?
Alaunos Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Alaunos Therapeutics a public company?
Yes. Alaunos Therapeutics, Inc. trades on Nasdaq under the ticker TCRT.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.